What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?

Saved in:
Bibliographic Details
Title: What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?
Authors: Wilson, Maria Aurora Roma1 (AUTHOR), Pozzilli, Paolo1,2,3 (AUTHOR) p.pozzilli@unicampus.it
Source: Journal of Diabetes & its Complications. Oct2025, Vol. 39 Issue 10, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:10568727
DOI:10.1016/j.jdiacomp.2025.109132